The risk of symptomatic intracranial hemorrhage after thrombolysis for acute stroke: Current concepts and perspectives
Background: Thrombolysis is the standard of treatment for acute ischemic stroke, with a time window of up to 4½ h from stroke onset. Despite the long experience with the use of recombinant tissue plasminogen activator and the adherence to protocols symptomatic intracranial hemorrhage (SICH) may occu...
Main Author: | Pedro J Modrego |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Annals of Indian Academy of Neurology |
Subjects: | |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2019;volume=22;issue=3;spage=336;epage=340;aulast=Modrego |
Similar Items
-
Diffuse Alveolar Hemorrhage After Intravenous Thrombolysis for Acute Ischemic Stroke
by: Mehtap, et al.
Published: (2019-12-01) -
Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke
by: Ting-Chun Lin, et al.
Published: (2018-11-01) -
A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients
by: Guo H, et al.
Published: (2021-07-01) -
Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis Administration in an Acute Ischemic Stroke Patient with Chronic Pontine Microbleeds, a Case Report
by: Samantha Anne S. Gutierrez, MD, et al.
Published: (2021-03-01) -
The role of leukoaraiosis on outcomes and recombinant tissue-plasminogen activator-related symptomatic intracerebral hemorrhages in acute stroke
by: Ezgi Sezer Eryildiz, et al.
Published: (2020-01-01)